September 2026
The global diabetic retinopathy market size is predicted to cross around USD 18.93 billion by 2035 from USD 10.89 billion in 2026 with a CAGR of 6.35%.
September 2026
The global diabetic neuropathy market size was exhibited at USD 5.18 billion in 2026 and is projected to hit around USD 9.64 billion by 2035, with a CAGR of 7.16%.
September 2026
The U.S. diabetic foot ulcer treatment market generated USD 3.87 billion in 2026, with prominent U.S. diabetic foot ulcer treatment market companies including 3M / Solventum, Smith+Nephew, Mölnlycke Health Care.
June 2026
The antidiabetics market size was evaluated at USD 116.17 billion in 2025 and is projected to reach around USD 262.85 billion by 2035, with a CAGR of 8.51%.
May 2026
The global diabetic kidney disease market size was valued at USD 3.25 billion in 2025 and is projected to hit around USD 5.23 billion by 2035 with a CAGR of 4.87%.
February 2026
The global diabetic foot ulcer treatment market size is projected to hit around USD 17.06 billion by 2035 from USD 9.67 billion in 2025 with a CAGR of 5.84%.
February 2026
The North America diabetic foot ulcer treatment market size is projected to hit around USD 9.31 billion by 2035 from USD 5.53 billion in 2026, with a CAGR of 5.96%.
February 2026
The global diabetic footwear market size reached USD 9.68 billion in 2025 and is projected to hit around USD 19.85 billion by 2035 with a CAGR of 7.45%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com